Ascentage Pharma Group International (ASPHF) Q3 2026 Earnings

18AugConfirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.32
-0.21
-0.1
0

Details

Expected EPS
-0.05522223036
Actual EPS
-0.3223242
Surprise EPS
-0.27
Surprise Percent
+483.69%

Description

Ascentage Pharma Group International (ASPHF) has reported earnings of -0.3223242 per share for Q3 2026.

0 Comments

Share your thoughts